Novo Nordisk, driving change to defeat diabetes

Driving change to prevent childhood obesity

Working with UNICEF to create healthier environments
Insulin100

To mark a life-saving discovery, we are celebrating a century of innovation in diabetes care
Net zero emissions by 2045

In addition to our 2030 environment targets, we have committed to net zero emissions across our entire value chain by 2045

Latest news

Novo Nordisk announces impact from Volume Based Procurement for insulin in China

Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research technology platform

Ozempic® 2.0 mg recommended for approval for the treatment of type 2 diabetes by the European Medicines Agency

Dear colleague

Please click here to go directly to our internal career site to view all our current job opening.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.

Investors

Share price

Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Annual Report